Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy.".
Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck S, Grignon DJ, Cheng L, Albany C, Hahn NM.
Thomas DE, et al. Among authors: beck s.
Urol Oncol. 2018 Jul;36(7):345. doi: 10.1016/j.urolonc.2018.05.003. Epub 2018 Jun 5.
Urol Oncol. 2018.
PMID: 29880459